Izotropic Corporation
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation … Read more
Izotropic Corporation (IZOZF) - Total Assets
Latest total assets as of October 2025: $447.06K USD
Based on the latest financial reports, Izotropic Corporation (IZOZF) holds total assets worth $447.06K USD as of October 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Izotropic Corporation - Total Assets Trend (2017–2025)
This chart illustrates how Izotropic Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Izotropic Corporation - Asset Composition Analysis
Current Asset Composition (April 2025)
Izotropic Corporation's total assets of $447.06K consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 66.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Izotropic Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Izotropic Corporation's current assets represent 95.4% of total assets in 2025, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 66.1% of total assets in 2025, down from 99.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Izotropic Corporation Competitors by Total Assets
Key competitors of Izotropic Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Izotropic Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Izotropic Corporation generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Izotropic Corporation is currently not profitable relative to its asset base.
Izotropic Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.07 | 0.05 | 50.47 |
| Quick Ratio | 0.07 | 0.05 | 50.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.50 Million | $ -4.55 Million | $ 4.16 Million |
Izotropic Corporation - Advanced Valuation Insights
This section examines the relationship between Izotropic Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 115.81 |
| Latest Market Cap to Assets Ratio | 32.66 |
| Asset Growth Rate (YoY) | 78.5% |
| Total Assets | $414.73K |
| Market Capitalization | $13.55 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Izotropic Corporation's assets at a significant premium ( 32.66x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Izotropic Corporation's assets grew by 78.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Izotropic Corporation (2017–2025)
The table below shows the annual total assets of Izotropic Corporation from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | $414.73K | +78.47% |
| 2024-04-30 | $232.38K | -47.44% |
| 2023-04-30 | $442.11K | -80.52% |
| 2022-04-30 | $2.27 Million | -51.59% |
| 2021-04-30 | $4.69 Million | +503.01% |
| 2020-04-30 | $777.21K | +129.23% |
| 2019-04-30 | $339.06K | -31.03% |
| 2018-04-30 | $491.64K | +228.44% |
| 2017-04-30 | $149.69K | -- |